About REMP
REMP is a company based in Oberdiessbach (Switzerland) founded in 1986 was acquired by Nexus Biosystems in September 2010. REMP offers products and services including Automated Sample Storage Systems, Limfinity LIMS, and GENEWIZ Services. REMP operates in a competitive market with competitors including Brooks Automation, Bridge to Life, Hemanext, Atelerix and Cellbox Solutions, among others.
- Headquarter Oberdiessbach, Switzerland
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Tecan
& 2 more
-
Employee Count
Not available
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of REMP
REMP offers a comprehensive portfolio of products and services, including Automated Sample Storage Systems, Limfinity LIMS, and GENEWIZ Services.
Systems for efficient cryogenic and ultra-cold sample storage.
Cloud-based system for laboratory information and sample tracking.
Offers sequencing and synthesis for research and clinical applications.
Funding Insights of REMP
Investors in REMP
REMP has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Tecan, Nexus Biosystems and Capvis.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
European investments are handled by Capvis, a private equity firm.
|
Locked | Locked | Locked | |
|
Automated laboratory instruments, robotics, and diagnostic solutions are provided.
|
Locked | Locked | Locked | |
|
Automated sample management systems and other products for life sciences and research organizations
|
Locked | Locked | Locked |
Investor details for REMP
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by REMP
Investment portfolio details for REMP
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - REMP
Detailed financials for REMP
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Remp Comparisons
Peer comparison for REMP
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of REMP
REMP operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Brooks Automation, Bridge to Life, Hemanext, Atelerix and Cellbox Solutions, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Vacuum robots for semiconductor wafer handling are developed.
|
|
| Locked | Locked | Locked |
Cold storage solutions for organ transplant preservation are provided.
|
|
| Locked | Locked | Locked |
Technologies for blood and product storage are developed.
|
|
| Locked | Locked | Locked |
Technology for cell storage and transportation is developed.
|
|
| Locked | Locked | Locked |
Portable devices for cell storage and transport are provided.
|
|
| Locked | Locked | Locked |
Thermal packaging solutions and cold chain monitoring services are provided.
|
Detailed competitors of REMP
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Remp
Complete news archive for REMP
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about REMP
REMP was founded in 1986 and raised its 1st funding round 14 years after it was founded.
REMP is headquartered in Oberdiessbach, Switzerland. It is registered at Oberdiessbach, Bern, Switzerland.
David Martyr is the current CEO of REMP.
REMP was founded in 1986 in Oberdiessbach, Switzerland, and operates within the pharmaceutical and life science sectors. Devices, consumables, software, and automated sample processing and storage systems are supplied to support industry needs. Biostorage solutions are provided primarily for biobanks and biopharma companies. The company is integrated into the Tecan group, following its acquisition by Nexus Biosystems in 2010 and the subsequent acquisition of Nexus by Brooks Automation.
REMP's top competitors include Brooks Automation, Hemanext and Bridge to Life.
REMP offers Automated Sample Storage Systems, Limfinity LIMS, and GENEWIZ Services.
REMP has 3 investors. Key investors include Tecan, Nexus Biosystems, and Capvis.